Dyne Therapeutics, Inc. (DYN) Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. ADMA Biologics, Inc. (ADMA) ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and […]
Read MoreRoot, Inc. (ROOT) Root, Inc. provides insurance products and services in the United States. The company offers automobile, homeowners, and renters insurance products. American Superconductor Corporation (AMSC) American Superconductor Corporation, together with its subsidiaries, provides megawatt-scale power resiliency solutions worldwide. Silence Therapeutics plc (SLN) Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules […]
Read MoreQ32 Bio Inc. (QTTB) Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Nkarta, Inc. (NKTX) Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. […]
Read MoreGyre Therapeutics, Inc. (GYRE) Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. Neurogene Inc. (NGNE) Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. MakeMyTrip Limited (MMYT) MakeMyTrip Limited, an online travel company, sells travel products and services in India, the United […]
Read MoreUnited Therapeutics Corporation (UTHR) United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Corbus Pharmaceuticals Holdings, Inc. (CRBP) Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. GeneDx Holdings […]
Read MoreDyne Therapeutics, Inc. is a biotechnology company focused on developing life-transforming therapies for patients with serious muscle diseases. The company utilizes its proprietary FORCE™ platform to deliver targeted therapies that address the underlying genetic causes of muscle disorders. Dyne Therapeutics’ pipeline includes treatments for diseases such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 […]
Read MoreDyne Therapeutics, Inc. (DYN) is a clinical-stage biotechnology company focused on developing transformative therapeutics for people living with serious muscle diseases caused by genetic mutations. The company is headquartered in Waltham, Massachusetts, and leverages its proprietary FORCE™ platform to create innovative oligonucleotide therapeutics designed to deliver drugs directly to muscle tissue, thereby overcoming significant challenges […]
Read MoreTaysha Gene Therapies, Inc. (TSHA) is a biotechnology company dedicated to developing and commercializing gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS). The company focuses on using adeno-associated viruses (AAVs) as vectors to deliver therapeutic genes to target cells, aiming to address the root causes of these diseases. […]
Read MoreNeurogene Inc. (NGNE) is a biotechnology company dedicated to developing life-changing genetic therapies for patients suffering from rare neurological diseases. Their primary focus is on creating innovative treatments that address the root causes of these disorders at the genetic level. Neurogene’s key product candidates include gene therapy programs aimed at conditions such as Batten disease […]
Read MoreStoke Therapeutics, Inc. (STOK) is a biotechnology company focused on developing innovative treatments for genetic diseases. Their primary aim is to address severe genetic disorders by upregulating protein expression using their proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform. This platform allows Stoke to precisely increase the production of proteins that are deficient due […]
Read MoreAbercrombie & Fitch Co. (ANF) Abercrombie & Fitch Co., through its subsidiaries, operates as an omnichannel retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally. MicroStrategy Incorporated (MSTR) MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. Neurogene Inc. (NGNE) […]
Read MoreHeron Therapeutics is a biotechnology company that focuses on developing and commercializing treatments to address unmet medical needs, particularly in the areas of pain management and oncology. The company leverages its proprietary Biochronomer drug delivery technology to create innovative therapies that can improve patient outcomes and quality of life.One of Heron Therapeutics’ key products is […]
Read MoreADC Therapeutics focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product is ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration and conditional approval from the European Commission for the treatment of […]
Read MoreVera Therapeutics, Inc. (VERA) Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Black Diamond Therapeutics, Inc. (BDTX) Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The Real Brokerage Inc. (REAX) […]
Read MoreImmunityBio, Inc. (IBRX) ImmunityBio, Inc., a clinical-stage biotechnology company, engages in discovering, developing, and commercializing next-generation immuno- and cellular therapies for cancer and infectious diseases in the United States and Europe. Universal Stainless & Alloy Products, Inc. (USAP) Universal Stainless & Alloy Products, Inc., together with its subsidiaries, manufactures and markets semi-finished and finished specialty steel products […]
Read More